Pay in 4 interest-free payments of $6.28 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Doering, C
Wilson, P
Among currently available agents, GLP-1 RAs - and tirzepatide in particular, based on the SURMOUNT-1 subgroup analysis - have the most substantial weight-loss evidence in this population, with efficacy appearing comparable to that observed in common obesity
GLP-1 agonists are peptides with high molecular weight, which typically limits milk transferbut direct lactation studies are unavailable
With a different concentration (e.g., 2.5 mg/mL), the same 0.5 mg dose would require 20 units
US$ 29.23
US$ 26.68
US$ 27.38
US$ 25.02
US$ 26.99
US$ 24.48
US$ 23.80
US$ 26.08
US$ 25.02
US$ 28.92
